Kailu in Inner Mongolia and Anhui Fengyuan Group signed a cooperation agreement for the Fengyuan (Northern) Green Zero-Carbon Biomanufacturing Industry Base Project, with a total investment of 15.5 billion yuan

Thread Content

On August 26, Kailu County in Inner Mongolia signed a Cooperation Agreement for the Fengyuan (Northern) Green Zero-Carbon Biomanufacturing Industry Base Project with Anhui Fengyuan Group Co., Ltd. According to the project cooperation agreement, the Fengyuan (Northern) Green Zero-Carbon Biomanufacturing Industry Base project has a total investment of 15.5 billion yuan. It encompasses three main areas: amino acid product projects, biomaterial projects, and bioenergy projects. Once fully operational, the project is expected to generate annual sales revenue of around 26 billion yuan. In the field of biomanufacturing, the Toyowa Group has, through independent research and development as well as partnerships with external parties, mastered the first-generation biomanufacturing technology that uses starch sugars as raw materials, as well as the second-generation biomanufacturing technology that utilizes straw for sugar production. This includes four key innovative platform technologies: 1) Technology for producing plant-derived humic acid simultaneously from cellulose derived from agricultural and forestry waste such as straw ； 2) Three major bio-based material platform technologies (polylactic acid, bio-based polyurethane, bio-based polycarbonate) ； 3) Three major bioenergy production technologies (cellulosic ethanol, biodiesel, biojet fuel) ； 4) Downstream development and application technologies for bio-based materials (industrial application technologies for bio-based materials such as biological fibers, bioplastics, bio-based green building materials, bio-based paints and coatings, bio-based adhesives, bio-leather, bio-based foams, bio-based elastomers, etc.). Meanwhile, the Toyohara Group has been striving to use second-generation biomanufacturing technology to develop green bio-based products such as biochemicals, biomaterials, bioenergy, and biopharmaceuticals, which are environmentally friendly, low-carbon, and non-toxic. According to available information, Fengyuan Group is a mixed-ownership enterprise controlled by its management team with state-owned shares involved. It is primarily engaged in the research and development of biotechnology, biopharmaceuticals, biomaterials, and bioenergy, as well as the commercialization of these technologies. It is an **innovative high-tech enterprise; it currently holds control over Fengyuan Pharmaceutical and has stakes in the listed company Yunding Technology. The group owns various industrial companies such as Fengyuan Biology, Fengyuan Pharmaceutical, Tiger Biology, Fengyuan Chemical Equipment, Fengyuan Food, and Fengyuan Agriculture, as well as trading companies like Fengyuan International Trade and Fengyuan Domestic Goods. It has also established biomanufacturing plants in Thailand, Hungary, and Brazil, using starch and glucose as raw materials to produce biochemicals such as organic acids and amino acids, which are used as food additives and feed additives. The group possesses two **level innovation platforms: a fermentation technology **engineering research center and a Fengyuan Pharmaceutical **level enterprise technology center.